{"id":509034,"date":"2020-09-29T18:40:01","date_gmt":"2020-09-29T18:40:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=509034"},"modified":"2020-09-29T18:40:01","modified_gmt":"2020-09-29T18:40:01","slug":"shigella-infections-market-insights-epidemiology-market-forecast-2030-by-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/shigella-infections-market-insights-epidemiology-market-forecast-2030-by-delveinsight_509034.html","title":{"rendered":"Shigella Infections Market Insights, Epidemiology, Market Forecast 2030 by DelveInsight"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1601350970.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Shigella Infections Market Insights, Epidemiology, Market Forecast 2030 by DelveInsight\" src=\"https:\/\/www.abnewswire.com\/uploads\/1601350970.jpeg\" alt=\"Shigella Infections Market Insights, Epidemiology, Market Forecast 2030 by DelveInsight\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>DelveInsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight&#8217;s &#8220;Shigella Infections &#8211; Market Insights, Epidemiology, and Market Forecast-2030&#8221; report delivers an in-depth understanding of the Shigella Infections, historical and forecasted epidemiology as well as the Shigella Infections market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/div>\n<p style=\"text-align: justify;\"><strong>DelveInsight<\/strong>&nbsp;launched a new report on&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/shigella-infections-market\"><strong><span style=\"text-decoration: underline;\">Shigella Infections &ndash; Market Insights, Epidemiology, and Market Forecast-2030<\/span><\/strong><\/a><\/p>\n<p style=\"text-align: justify;\">DelveInsight&rsquo;s &ldquo;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/shigella-infections-market\"><strong>Shigella Infections Market<\/strong><\/a>&rdquo;&nbsp;report delivers an in-depth understanding of the Shigella Infections, historical and forecasted epidemiology as well as the Shigella Infections market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<p style=\"text-align: justify;\"><strong>The key fact of the report:<\/strong><br \/><strong>&ldquo;Shigella infections or Shigellosis causes approximately 450,000 cases of diarrhoea in the United States annually.&rdquo;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Key benefits of the report:<\/strong><br \/>1. Shigella infections market report covers a descriptive overview and comprehensive insight of the Shigella infections epidemiology and Shigella infections market in the 7 MM (the United States, EU5 (Germany, Spain, France, Italy, UK) &amp; Japan.)<br \/>2. Shigella infections market report provides insights on the current and emerging therapies.<br \/>3. Shigella infections market report provides a global historical and forecasted market covering drug outreach in 7 MM.<br \/>4. Shigella infections market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Shigella infections market.<\/p>\n<p style=\"text-align: justify;\"><strong>View full report:&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/shigella-infections-market\">https:\/\/www.delveinsight.com\/report-store\/shigella-infections-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>The key players in Shigella infections market are:<\/strong><\/p>\n<p style=\"text-align: justify;\">1. LimmaTech Biologics AG<br \/>2. GlaxoSmithKline<br \/>3. Immuron<\/p>\n<p style=\"text-align: justify;\"><strong>The launch of the emerging therapies is expected to significantly impact Shigella infections treatment scenario in the upcoming years:-<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Drugs covered:<\/strong><br \/>1. GSK3536852A<br \/>and others<\/p>\n<p style=\"text-align: justify;\"><strong>Table of contents<\/strong><\/p>\n<p style=\"text-align: justify;\">1. Report Introduction<br \/>2. Executive Summary<br \/>3. SWOT analysis<br \/>4. Shigellosis Patient Share (%) Overview at a Glance<br \/>5. Shigella infections Market Overview at a Glance<br \/>6. Shigella infections Disease Background and Overview<br \/>7. Shigella infections Epidemiology and Patient Population<br \/>8. Country-Specific Patient Population of Shigellosis<\/p>\n<p style=\"text-align: justify;\">8.1. United States<br \/>8.2. EU5<br \/>8.2.1. Germany<br \/>8.2.2. France<br \/>8.2.3. Italy<br \/>8.2.4. Spain<br \/>8.2.5. United Kingdom<br \/>8.3. Japan<br \/>9. Current Shigella infections Treatment and Medical Practices<br \/>10. Unmet Needs<br \/>11. Shigella infections Emerging Therapies<br \/>12. Key Cross Competition<br \/>12.1. GSK3536852A: GlaxoSmithKline<br \/>13. Shigellosis Market Outlook<br \/>14. Country-Wise Market Analysis (2017&ndash;2030)<br \/>14.1. United States Market Size<br \/>14.2. Germany Market Size<br \/>14.3. France Market Size<br \/>14.4. Italy Market Size<br \/>14.5. Spain Market Size<br \/>14.6. United Kingdom Market Size<br \/>14.7. Japan Market Size<br \/>15. Market Access and Reimbursement of Therapies<br \/>16. Market drivers<br \/>17. Market barriers<br \/>18. Appendix<br \/>19. Report Methodology<br \/>20. DelveInsight Capabilities<br \/>21. Disclaimer<br \/>22. About DelveInsight<\/p>\n<p style=\"text-align: justify;\"><strong>Related reports:<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong><span style=\"text-decoration: underline;\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/shigella-infections-epidemiology-forecast\">Shigella Infections &ndash; Epidemiology Forecast to 2030<\/a><\/span><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong><span style=\"text-decoration: underline;\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/shigella-infections-pipeline-insight\">Shigella Infections Pipeline Insight, 2020<\/a><\/span><\/strong><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56431.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Kritika Rehani<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=shigella-infections-market-insights-epidemiology-market-forecast-2030-by-delveinsight\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 9193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> Nevada<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=shigella-infections-market-insights-epidemiology-market-forecast-2030-by-delveinsight\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight Business Research LLP DelveInsight&#8217;s &#8220;Shigella Infections &#8211; Market Insights, Epidemiology, and Market Forecast-2030&#8221; report delivers an in-depth understanding of the Shigella Infections, historical and forecasted epidemiology as well as the Shigella Infections market trends in the United States, EU5 &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/shigella-infections-market-insights-epidemiology-market-forecast-2030-by-delveinsight_509034.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,406,404],"tags":[],"class_list":["post-509034","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/509034","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=509034"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/509034\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=509034"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=509034"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=509034"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}